2018
DOI: 10.1093/ecco-jcc/jjx180.599
|View full text |Cite
|
Sign up to set email alerts
|

P472 Impact of anti-TNF-alfa therapy on colectomy rates and indications for surgery in Ulcerative Colitis: Comparison of two patient cohorts from 2005 to 2007 and 2014 to 2016

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…A systematic review of population studies has suggested that the rate of colectomy for UC has reduced since the 1950s due to advances in medical therapy 6 . Biological medications such as infliximab have proved effective as rescue therapy in acute UC, with clinical trials reporting data on colectomy rates up to two years after treatment for moderate and severe colitis suggesting a reduction in colectomy rate vs placebo 7‐9 . The National Institute for Clinical Excellence (NICE) first licenced infliximab use in the NHS for patients with moderate to severe UC in December 2008 10 .…”
Section: Introductionmentioning
confidence: 99%
“…A systematic review of population studies has suggested that the rate of colectomy for UC has reduced since the 1950s due to advances in medical therapy 6 . Biological medications such as infliximab have proved effective as rescue therapy in acute UC, with clinical trials reporting data on colectomy rates up to two years after treatment for moderate and severe colitis suggesting a reduction in colectomy rate vs placebo 7‐9 . The National Institute for Clinical Excellence (NICE) first licenced infliximab use in the NHS for patients with moderate to severe UC in December 2008 10 .…”
Section: Introductionmentioning
confidence: 99%